abrdn Healthcare Investors
18,66 €
▼
-0,19 €
(-1,02%)
ISIN
US87911J1034
Typ
ETF
Stand
18.09.2026
Aktueller Kurs
Lade Kursdaten...
Beschreibung
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Profil
- Name
- abrdn Healthcare Investors
- ISIN
- US87911J1034
- Kategorie
- Global Equity
- Fokus
- Healthcare
- Ausschüttungsfrequenz
- 4
- Anzahl Positionen
- 97
Top-Holdings
GILEAD SCIENCES INC 6.88%
AMGEN INC 5.74%
Regeneron Pharmaceuticals, Inc. 5.51%
Vertex Pharmaceuticals Incorporated 4.85%
ASTRAZENECA PLC-SPONS ADR 3.22%
UNITEDHEALTH GROUP INC 2.86%
Biogen Inc. 2.82%
Sarepta Therapeutics, Inc. 2.6%
ELI LILLY & CO 2.52%
BioMarin Pharmaceutical Inc. 2.49%
BIONTECH SE-ADR 2.47%
Alnylam Pharmaceuticals, Inc. 2.4%
ARGENX SE - ADR 2.05%
Illumina, Inc. 1.7%
AbbVie Inc. 1.66%
Intuitive Surgical, Inc. 1.61%
ABBOTT LABORATORIES 1.6%
Summit Therapeutics Inc. 1.56%
UNIQURE NV 1.47%
Neurocrine Biosciences, Inc. 1.44%
Thermo Fisher Scientific Inc. 1.44%
State Street Global Advisors 1.4%
MERCK & CO. INC. 1.3%
Intra-Cellular Therapies, Inc. 1.26%
Insmed Incorporated 1.26%
VAXCYTE INC 1.25%
CYTOKINETICS INC 1.06%
ULTRAGENYX PHARMACEUTICAL IN 0.93%
Immunovant, Inc. 0.9%
Elevance Health Inc. 0.87%
INSPIRE MEDICAL SYSTEMS INC 0.86%
Ionis Pharmaceuticals, Inc. 0.83%
Becton, Dickinson and Company 0.77%
BRISTOL-MYERS SQUIBB CO 0.7%
JOHNSON & JOHNSON 0.66%
XENON PHARMACEUTICALS INC 0.65%
KRYSTAL BIOTECH INC 0.62%
GUARDANT HEALTH INC 0.61%
MODERNA INC 0.58%
Oculis Holding AG 0.57%
Danaher Corporation 0.56%
TEVA PHARMACEUTICAL-SP ADR 0.53%
Boston Scientific Corporation 0.53%
MEDPACE HOLDINGS INC 0.52%
IDEAYA BIOSCIENCES INC 0.51%
Zoetis Inc. 0.5%
Arrowhead Pharmaceuticals, Inc. 0.48%
Travere Therapeutics, Inc. 0.48%
DENALI THERAPEUTICS INC 0.47%
TENET HEALTHCARE CORP 0.47%
Amylyx Pharmaceuticals, Inc. 0.46%
Arcutis Biotherapeutics, Inc. 0.46%
AKERO THERAPEUTICS INC 0.45%
MOLINA HEALTHCARE INC 0.45%
HCA Healthcare, Inc. 0.44%
Alkermes plc 0.44%
TANDEM DIABETES CARE INC 0.44%
Medtronic plc 0.43%
SCHOLAR ROCK HOLDING CORP 0.41%
Halozyme Therapeutics, Inc. 0.4%
ADAPTIVE BIOTECHNOLOGIES 0.39%
Geron Corporation 0.37%
Axsome Therapeutics, Inc. 0.35%
DEXCOM INC 0.35%
Structure Therapeutics Inc. 0.32%
CBOE GLOBAL MARKETS, INC. 0.31%
CO-OPERATIVE BANK HOLDN 0.31%
RHYTHM PHARMACEUTICALS INC 0.3%
Edgewise Therapeutics, Inc. 0.28%
MERUS NV 0.24%
AVANTOR INC 0.24%
Nuvalent, Inc. 0.23%
Janux Therapeutics, Inc. 0.23%
INSULET CORP 0.23%
Stryker Corporation 0.22%
McKesson Corporation 0.2%
XENCOR INC 0.18%
Vir Biotechnology, Inc. 0.18%
INEOS US PETROCHEM LLC 0.18%
IDEXX Laboratories, Inc. 0.16%
TScan Therapeutics, Inc. 0.15%
Chicago Mercantile Exchange 0.14%
GRAIL INC 0.14%
89bio, Inc. 0.13%
EYEPOINT INC 0.12%
Pyxis Oncology, Inc. 0.1%
Marinus Pharmaceuticals, Inc. 0.08%
Rallybio Corporation 0.07%
NOVAVAX INC 0.03%
Praxis Precision Medicines, Inc. 0.03%
Chinook Therapeutics Inc 0.02%
Mural Oncology plc 0.01%
NOVABRIDGE BIOSCIENCES 0%
Galera Therapeutics, Inc. 0%
CONTRA FUSION PHARMACE 0%
TETRAPHASE PHARMACEUTICALS INC 0%
CONTRA SPECTRUM PHARMA 0%
Performance
Keine Performance Daten vorhanden.